Research progress of Yttrium-90 in the treatment of unresectable and chemotherapy-tolerant colorectal liver metastasis / 中华消化外科杂志
Chinese Journal of Digestive Surgery
; (12): 200-202, 2016.
Article
in Zh
| WPRIM
| ID: wpr-489773
Responsible library:
WPRO
ABSTRACT
Colorectal liver metastasis (CRLM) is a common liver metastatic tumor with poor prognosis.It was very difficult to treat patients with unresectable and chemotherapytolerant CRLM.With the tumor control rate ranging from 63% to 78%,Yttrium-90 is both safe and effective in treating unresectable and chemotherapy-tolerant CRLM.The median survival time is 10.5 months,and the 1-,2-,3-year overall survival rates of patients are 44%,20% and 14% respectively.For a certain portion of patients,Yttrium-90 has distinct advantages over mo lecular targeted drugs and other local minimally invasive treatment.Though Yttrium-90 treatment has showed certain curative effect,its safety and effectiveness require further confirmation through multi-center randomized controlled trial.
Full text:
1
Database:
WPRIM
Type of study:
Clinical_trials
Language:
Zh
Journal:
Chinese Journal of Digestive Surgery
Year:
2016
Document type:
Article